Research map: Refining a preclinical model of viral myocarditis in accordance with biotech standards

Back to the article

Papers in this map

  1. Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology · Roberto Miguel Lang · 2005 · 11389 citations · Cited by this paper
  2. A mouse model of mechanical stress injury to the basal ganglia using thermosensitive PNIPAM hydrogel for intracerebral hemorrhage research · 2026 · Related
  3. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging · Roberto Miguel Lang · 2015 · 8520 citations · Cited by this paper
  4. Mechanistic investigation of Liujing Toutong tablet in the treatment of cerebral ischemia–reperfusion injury in rats by the integration of serum pharmacochemistry and metabolomics · 2026 · Related
  5. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions · Carsten Tschöpe · 2020 · 1239 citations · Cited by this paper
  6. Strategies for inducing diabetes in laboratory animals: Advances from chemical, surgical, immunologic, dietary, and genetic approaches · 2026 · Related
  7. The Lancet Commission on lessons for the future from the COVID-19 pandemic · Jeffrey David Sachs · 2022 · 902 citations · Cited by this paper
  8. A novel mouse model of chronic Pseudomonas aeruginosa infection inducing bronchiectasis‐like phenotype · 2026 · Related
  9. Viral myocarditis—diagnosis, treatment options, and current controversies · Ari T. Pollack · 2015 · 703 citations · Cited by this paper
  10. ApoE ‐ and Cfh‐deficient mice exhibit structural and molecular features of human early–intermediate retinal degeneration · 2026 · Related
  11. Diagnostics for COVID-19: moving from pandemic response to control · Rosanna Wai Wan Peeling · 2021 · 509 citations · Cited by this paper
  12. Stem cell–based therapies for type 1 diabetes: Progress in differentiation, clinical translation, and immune protection · 2026 · Related
  13. 2025 ESC Guidelines for the management of myocarditis and pericarditis · Jeanette Schulz‐Menger · 2025 · 410 citations · Cited by this paper
  14. Cell therapy comparison of dental pulp stem cells, hepatocytes, and their exosomes for liver fibrosis treatment in rats · 2026 · Related
  15. Guidelines for measuring cardiac physiology in mice · Merry L. Lindsey · 2018 · 350 citations · Cited by this paper
  16. Chronic alcohol consumption compromises gut barrier integrity and promotes endotoxemia: Implications for sepsis susceptibility in immunocompromised hosts · 2026 · Related
  17. From Infection to Autoimmunity · DeLisa Fairweather · 2001 · 332 citations · Cited by this paper
  18. Clotrimazole‐loaded PLGA microparticles for local drug delivery to the vagina: Shape does matter · 2026 · Related
  19. Echocardiographic Speckle-Tracking Based Strain Imaging for Rapid Cardiovascular Phenotyping in Mice · Michael W Bauer · 2011 · 251 citations · Cited by this paper
  20. USB1 deficiency disrupts neutrophil maturation via RNA dysregulation independent of global pre‐ mRNA splicing · 2026 · Related
  21. Towards standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function · Serena Zacchigna · 2020 · 223 citations · Cited by this paper
  22. Coxsackievirus-induced myocarditis in mice: A model of autoimmune disease for studying immunotoxicity · DeLisa Fairweather · 2006 · 211 citations · Cited by this paper
  23. Interferon-γ Protects against Chronic Viral Myocarditis by Reducing Mast Cell Degranulation, Fibrosis, and the Profibrotic Cytokines Transforming Growth Factor-β1, Interleukin-1β, and Interleukin-4 in the Heart · DeLisa Fairweather · 2004 · 199 citations · Cited by this paper
  24. Myocarditis in Humans and in Experimental Animal Models · Przemysław Błyszczuk · 2019 · 176 citations · Cited by this paper
  25. Update on coxsackievirus B3 myocarditis · DeLisa Fairweather · 2012 · 174 citations · Cited by this paper
  26. Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomes · Weijian Hang · 2020 · 169 citations · Cited by this paper
  27. Group B coxsackievirus myocarditis and pancreatitis: Connection between viral virulence phenotypes in mice · Steven Tracy · 2000 · 145 citations · Cited by this paper
  28. New approaches in small animal echocardiography: imaging the sounds of silence · Rashmi Ram · 2011 · 144 citations · Cited by this paper
  29. Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice · Charles J. Gauntt · 1979 · 138 citations · Cited by this paper
  30. IL-12 Protects against Coxsackievirus B3-Induced Myocarditis by Increasing IFN-γ and Macrophage and Neutrophil Populations in the Heart · DeLisa Fairweather · 2005 · 136 citations · Cited by this paper
  31. The role of viruses in the production of heart disease · George E. Burch · 1972 · 129 citations · Cited by this paper
  32. Epidemiological Impact of Myocarditis · Ainoosh Golpour · 2021 · 125 citations · Cited by this paper
  33. Testosterone and interleukin-1β increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n · Michael J. Coronado · 2012 · 120 citations · Cited by this paper
  34. A background Ca2+entry pathway mediated by TRPC1/TRPC4 is critical for development of pathological cardiac remodelling · Juan E. Camacho Londoño · 2015 · 108 citations · Cited by this paper
  35. Advancing the 3Rs: innovation, implementation, ethics and society · Herwig Grimm · 2023 · 108 citations · Cited by this paper
  36. CD69 Limits the Severity of Cardiomyopathy After Autoimmune Myocarditis · Aránzazu Cruz‐Adalia · 2010 · 101 citations · Cited by this paper
  37. Using Recombinant Coxsackievirus B3 To Evaluate the Induction and Protective Efficacy of CD8+T Cells during Picornavirus Infection · Mark K. Slifka · 2001 · 98 citations · Cited by this paper
  38. Sex differences in coxsackievirus B3-induced myocarditis: IL-12Rβ1 signaling and IFN-γ increase inflammation in males independent from STAT4 · Sylvia Frisancho‐Kiss · 2006 · 89 citations · Cited by this paper
  39. Complement Receptor 1 and 2 Deficiency Increases Coxsackievirus B3-Induced Myocarditis, Dilated Cardiomyopathy, and Heart Failure by Increasing Macrophages, IL-1β, and Immune Complex Deposition in the Heart · DeLisa Fairweather · 2006 · 82 citations · Cited by this paper

Source: OpenAlex (CC0)